70 related articles for article (PubMed ID: 25747991)
1. CCL17 production by mouse langerhans cells stimulated with Staphylococcus aureus cell wall components.
Matsui K; Tofukuji S; Ikeda R
Biol Pharm Bull; 2015; 38(2):317-20. PubMed ID: 25747991
[TBL] [Abstract][Full Text] [Related]
2. Peptidoglycan in combination with muramyldipeptide synergistically induces an interleukin-10-dependent T helper 2-dominant immune response.
Matsui K; Ikeda R
Microbiol Immunol; 2014 Apr; 58(4):260-5. PubMed ID: 24479522
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
Matsui K; Nishikawa A
J Investig Allergol Clin Immunol; 2011; 21(5):354-62. PubMed ID: 21905498
[TBL] [Abstract][Full Text] [Related]
4. Peptidoglycan-induced T helper 2 immune response in mice involves interleukin-10 secretion from Langerhans cells.
Matsui K; Nishikawa A
Microbiol Immunol; 2013 Feb; 57(2):130-8. PubMed ID: 23163836
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of Schefflera leucantha extract on production of allergic mediators by Langerhans cells and mast cells.
Matsui K; Wirotesangthong M; Thanakijcharoenpath W; Mungmee C; Nishikawa A
J Investig Allergol Clin Immunol; 2010; 20(6):463-8. PubMed ID: 21243929
[TBL] [Abstract][Full Text] [Related]
6. Peptidoglycan from Staphylococcus aureus induces T(H)2 immune response in mice.
Matsui K; Nishikawa A
J Investig Allergol Clin Immunol; 2012; 22(2):80-6. PubMed ID: 22533229
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin.
Matsui K; Wirotesangthong M; Nishikawa A
Clin Exp Allergy; 2007 Apr; 37(4):615-22. PubMed ID: 17430360
[TBL] [Abstract][Full Text] [Related]
8. Peptidoglycan from Staphylococcus aureus induces IL-4 production from murine spleen cells via an IL-18-dependent mechanism.
Matsui K; Wirotesangthong M; Nishikawa A
Int Arch Allergy Immunol; 2008; 146(3):262-6. PubMed ID: 18270494
[TBL] [Abstract][Full Text] [Related]
9. Mast Cells Stimulated with Peptidoglycan from Staphylococcus aureus Augment the Development of Th1 Cells.
Matsui K; Kanai S; Ikuta M; Horikawa S
J Pharm Pharm Sci; 2018; 21(1):296-304. PubMed ID: 30012242
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis.
Miyano K; Matsushita S; Tsuchida T; Nakamura K
J Dermatol; 2016 Sep; 43(9):1024-9. PubMed ID: 26892271
[TBL] [Abstract][Full Text] [Related]
11. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.
Juárez-Verdayes MA; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):53-62. PubMed ID: 22890731
[TBL] [Abstract][Full Text] [Related]
12. Effects of Macrolide Antibiotics on Th1 Cell and Th2 Cell Development Mediated by Langerhans Cells.
Matsui K; Tamai S; Ikeda R
J Pharm Pharm Sci; 2016; 19(3):357-366. PubMed ID: 27806249
[TBL] [Abstract][Full Text] [Related]
13. Norfloxacin, a Fluoroquinolone Antibiotic, Inhibits Langerhans Cell-Mediated Th1 and Th2 Cell Development.
Matsui K; Kashima A; Motegi A
J Pharm Pharm Sci; 2019 Apr; 22(1):122-130. PubMed ID: 30974054
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice.
Matsui K; Nishikawa A
Clin Exp Allergy; 2005 Mar; 35(3):382-7. PubMed ID: 15784119
[TBL] [Abstract][Full Text] [Related]
15. Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis.
Matsui K; Motohashi R; Nishikawa A
J Interferon Cytokine Res; 2000 Mar; 20(3):321-4. PubMed ID: 10762080
[TBL] [Abstract][Full Text] [Related]
16. Analysis of signaling pathways involved in peptidoglycan-induced RANTES production from murine Langerhans cells.
Matsui K; Wirotesangthong M; Nishikawa A
Int Arch Allergy Immunol; 2009; 149(2):167-72. PubMed ID: 19127075
[TBL] [Abstract][Full Text] [Related]
17. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
[TBL] [Abstract][Full Text] [Related]
18. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
19. Glyteer, Soybean Tar, Impairs IL-4/Stat6 Signaling in Murine Bone Marrow-Derived Dendritic Cells: The Basis of Its Therapeutic Effect on Atopic Dermatitis.
Takemura M; Nakahara T; Hashimoto-Hachiya A; Furue M; Tsuji G
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29649105
[TBL] [Abstract][Full Text] [Related]
20. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
